newsfilter
← Latest News
GlobeNewswire·

Nasdaq Grants OpGen 180-Day Extension to Meet Minimum Bid Price Requirement

ROCKVILLE, Md., Aug. 31, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN, "OpGen"))), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that it has received w